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Abstract: Whereas brachial blood pressure (BP) is still considered the gold standard for the estimation of cardiovascular
risk in all clinical trials and guidelines, scientific interest is shifting towards central hemodynamics and the scientific
community is experiencing a whole new revolution with the emergence of novel cardiovascular markers such as the ambulatory measurement of central BP and arterial stiffness. Central BP has already started to demonstrate its superiority
over peripheral BP as a better and more reliable predictor of end-organ damage in cardiovascular diseases. Furthermore,
ambulatory measurement of central BP and pulse wave velocity are expected to add much more useful information towards a more integrated assessment of cardiovascular risk and profile. However, more research is required before these
novel markers could be incorporated in the everyday practice of BP measurement.
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INTRODUCTION
Cardiovascular disease is the leading cause of death
worldwide and hypertension is a major risk factor. Although
cardiovascular medicine has presented novelties in the therapeutic field, brachial blood pressure (BP) is still considered
the gold standard for screening, diagnosis and management
of arterial hypertension and peripheral BP is still used as a
major determinant of cardiovascular risk in clinical trials.
However, in the recent years central hemodynamics,
namely central Systolic (cSBP) and Diastolic blood pressure
(cDBP), pulse pressure (PP) and measurement of arterial
stiffness, have emerged as novel parameters of cardiovascular risk, mortality and target organ damage in essential hypertension (EH). As a result, new devices have been invented, shifting cardiovascular research from a peripheral to
a more central level. In that sense, ambulatory measurement
of arterial stiffness and central blood pressure (cBP) could
provide useful information over and above the usual measurements used in the everyday clinical practice.
PATHOPHYSIOLOGY AND MEASUREMENT OF
ARTERIAL STIFFNESS
Arterial stiffness describes a non-compliant artery that is
a vessel unable to distend in response to different pressure
changes. The two major determinants of arterial stiffness are
arterial hypertension and aging. Their etiologic relationship
resides in the structural and functional alterations that they
provoke to the arterial wall, including smooth muscle
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hypertrophy, increased collagen deposition, degradation of
elastic fibers and endothelial dysfunction [1-5].
The pathophysiological substrate of arterial stiffness lies
on the velocity with which pulse wave travels along the arterial tree and the interrelationship between the incident and
the reflected wave of the pressure waveform. Every time the
heart beats a systole, an incident pulse wave generates at the
junction with the aorta and propagates along the arterial tree.
Propagation continues unimpeded until the pulse wave meets
areas of discontinuity of the arterial wall, mainly the high
resistance arterioles, thus generating a reflected wave [6]. In
normal, healthy and young individuals where arteries are
elastic and compliant, the reflected wave travels back towards the aorta and meets the oncoming incident wave during the early diastole thereby increasing diastolic pressure
and facilitating coronary perfusion. However, in adults older
than 50 years old and in elderly people, where aging and
hypertension progressively stiffen the arteries, a different
pattern of circulation exists. The incident wave is reflected in
a much earlier point of the arterial tree and its reflected
waveform travels much faster along the hardened arterial
wall in a way that coincides with the oncoming incident
wave during systole. The net result is augmentation of the
cSBP and reduction of the diastolic pressure compromising
the perfusion of the coronary arteries. At the same time, systolic hypertension increases the afterload of the heart thereby
producing left ventricular hypertrophy and in the long term,
heart dysfunction [7-12]. Furthermore, increased arterial
stiffness is associated with progressive microvascular damage which compromises renal and cerebral function [13, 14].
The velocity at which the pulse wave travels along the
arterial tree is the most direct marker of arterial stiffness and
has been established as the gold standard for its measurement. The most common technique consists of measuring the
2013 Bentham Open
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distance that a pulse wave covers between two steady body
points (carotid and femoral artery) divided by the time
needed to reach these sites under simultaneous electrocardiographic monitoring [15]. The selected arteries provide the
advantage of a superficial, easy to access location whereas
in-between them, lies almost the whole of the aorta which is
the major vessel subject to arterial stiffening. In that Sense,
pulse wave velocity (PWV) is a simple, non-invasive, reproducible technique and several lines of evidence have proved
its significance as an independent prognostic factor of cardiovascular morbidity and mortality in patients with hypertension, diabetes mellitus type II, end-stage renal disease as
well as in the general population [16-25]. The aforementioned value has established PWV as a marker of subclinical
organ damage according to the latest guidelines of the European Society of Hypertension and European Society of Cardiology [26].
Despite the important relationship of arterial stiffness
and PWV with significant hemodynamic components of the
central arteries, paradoxically little research had been done
so far in the field of cBP parameters.
FROM PERIPHERAL TO CENTRAL BP
Peripheral BP measurement has for long been and still is
the established technique for evaluating arterial hypertension
and cardiovascular risk, although we know that differences
between peripheral and cBP exist.
In young healthy subjects cBP is lower compared to peripheral BP due to a physiological phenomenon called PP
amplification. At this age, PP travels from the central, elastic
arteries towards the smaller, muscular and more resistant
arteries of the periphery thereby undergoing an augmentation
of its amplitude. As a result, brachial BP can be as high as
30mmHg more compared to cBP. On the other hand, by aging the opposite effect is observed. Central arteries become
stiffer and cSBP increases at a level higher than that of the
periphery due to the magnitude of the reflected waves arriving at the heart. In addition, cBP represents more closely and
more realistically the true load of the left ventricle because
of its proximity to the key organs, including the heart [11,
27-32]. Taking these two factors into account, someone can
conclude that the measurement of brachial BP in an elderly
individual may not represent the true “hypertensive” load
and his total cardiovascular risk because the central burden
that strains his heart may be even larger.
The notion that cBP represents the true load of the heart
pump and consequently the real cardiovascular risk, has been
the epicenter of interest of a growing number of trials. As a
matter of fact, much research has focused lately on demonstrating whether central arterial pressure could turn out to be
a better marker of target organ damage and whether it could
provide more reliable information regarding cardiovascular
risk assessment. The first studies to be conducted, included
patients with end-stage renal disease and indeed, underlined
the role of cBP parameters in predicting all-cause mortality
[33-35]. Since then, accumulating scientific evidence has
proved that cBP can predict better cardiovascular events and
can actually be an independent factor of cardiovascular morbidity and mortality [36-43]. Furthermore, it has been shown
that different anti-hypertensive drugs may exert similar im-
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pact on peripheral BP whereas on the other hand, achieve
different levels of cBP reduction [44-51]. Interestingly, various reductions in cBP resulted in different cardiovascular
outcomes, an observation that further highlights the role of
cBP as a better marker of target organ damage and cardiovascular risk [42, 45, 52].
Since accumulating evidence points towards a greater
necessity for assessing the central hemodynamics, newer,
non-invasive techniques for approaching these phenomena
have emerged. Apart from piezo-electronic techniques
(Complior) and tonometric methods (SphygmoCor), the recent advent of oscillometric devices (Arteriograph, Mobil-ograph) has offered the opportunity to measure peripheral and
cBP parameters, including 24h monitoring of their variability
[53, 54].
SIGNIFICANCE OF 24H AMBULATORY MEASUREMENT OF ARTERIAL STIFFNESS AND CENTRAL BLOOD PRESSURE
Although research in cardiovascular field has started to
demonstrate the superiority of central over peripheral BP,
there are characteristics not fully investigated yet, including
cBP and PWV variability. In this context, since peripheral
BP levels present a circadian rhythm during the day, it
seemed reasonable that a similar pattern for cBP and PWV
could exist. However, almost all trials conducted so far included BP measurements at resting conditions whereas variability of PWV has never been studied before.
The study by Luzardo et al. was one of the first attempts
to assess ambulatory cBP and arterial stiffness parameters.
The investigators enrolled 115 volunteers between 28 and 64
years old from their working enviroment. Although they
were not a representative sample of the general population,
the volunteers underwent tonometric and oscillometric
measurements of arterial stiffness and cBP parameters under
resting and ambulatory conditions. Measurements were performed using the validated Sphygmocor and Mobil-O-graph
devices. Despite slight differences between cPP and PWV
values among the two methods, the investigators proved that
ambulatory, non-invasive measurement of cBP is a feasible
procedure. Nevertheless, the study focused on comparing the
values recorded between a tonometric and an oscillometric
device and did not correlate possible diurnal changes of cBP
to the established changes of peripheral BP. In addition, the
ambulatory measurement of cBP did not include early morning and late night measurements, two time periods where the
most important pathophysiologic alterations in peripheral BP
take place [55].
More recently, Williams and his colleagues conducted
the first multicenter, randomized, controlled, clinical trial in
order to assess the 24h circadian profile of cBP. In addition,
the investigators have been the pioneers in comparing, simultaneously, ambulatory cBP changes with the diurnal
variation of peripheral BP. For the purposes of the study, the
investigators enrolled 171 men and women with a mean age
of 53 years old and a history of EH. After a wash-out period,
participants were randomized into two treatment groups receiving either a direct renin inhibitor or an angiotensin receptor blocker. At the beginning and at the end of the study,
ambulatory peripheral BP and cBP parameters were meas-

84 The Open Hypertension Journal, 2013, Volume 5

ured using a conventional, cuff-based, oscillometric device
(Spacelabs) and a tonometric ambulatory BP monitoring
device (BPro) at the same time. The study demonstrated that
cBP changes throughout the day exhibit a similar pattern of
variability just like the diurnal fluctuation of brachial BP.
The observed diurnal pattern of both central and peripheral
pressure remained the same even after administration of BP
lowering agents suggesting that BP reduction does not play a
role in between pressure’s inter-variability. However, of major interest was the observation that cBP levels remained
lower than those of peripheral pressure for the whole 24h
period whereas, and more significantly, exhibited a lower
nocturnal dipping pattern compared to that of brachial pressure [56]. Whether this phenomenon is just a normal consequence of sleep or whether there are other implicating factors
remains unknown and needs further investigation due to its
apparent major clinical importance. Given the fact that the
incidence of cardiovascular events is higher in non-dipper
hypertensive individuals [26], someone could conclude that
the less pronounced dipping profile of cBP could have a
much more adverse impact on cardiovascular outcomes. In
that sense, central pressure and its fluctuations could represent a new therapeutic target emphasizing the need for further research in the field of ambulatory monitoring of cBP.
Another novel observation derived from the ambulatory
monitoring of cBP, is the gradual decline of the difference
between brachial and cSBP during the approach of night
(with cBP falling less as mentioned above) as opposed to its
sharp increase at the time of waking in the morning [56].
Until larger-scale trials come into sight, the phenomenon
will continue to be under investigation.
Whereas cBP variability has started to be in the epicenter of scientific interest, with the first trials coming up with
notable, initial observations, ambulatory measurement of
PWV continues to be a virgin field. Remarkably, no trial has
consistently studied so far the variations of PWV throughout
the day and as matter of fact, no correlations have been made
between the diurnal fluctuation of PWV (if such a pattern
exists) and the variability of peripheral or cBP. A limiting
factor against ambulatory arterial stiffness measurement
seems to be hydrostatic pressure. When moving from the
supine to an upright position, hydrostatic pressure across the
aorta increases, thereby creating a pressure gradient. Taking
into account the fact the PWV depends heavily on arterial
pressure, someone can conclude that variations of BP during
postural movements could negatively affect the precise
measurement of arterial stiffness parameters. The observed
obstacle is one of the reasons why efforts to obtain ambulatory PWV measurements are still confined to a very rudimental, experimental level [57, 58]. In this context, until
more reliable methods for the ambulatory measurement of
PWV come up, diurnal variation of arterial stiffness and its
possible applications - implications will continue to be a
promising field of cardiovascular research.
CONCLUSIONS
Whereas peripheral BP continues to be the point of reference of all algorithms and guidelines regarding arterial
hypertension and cardiovascular risk, it seems reasonable
that in the very near future measurement of cBP will play a
major role in cardiovascular risk stratification and treatment.
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Mounting evidence from large-scale trials has demonstrated the significance of cBP as a better marker of target
organ damage and consequently as a more reliable predictor
of cardiovascular morbidity and mortality. In addition, it has
been demonstrated that antihypertensive treatment can provoke different changes in cBP parameters consequently
changing cardiovascular outcomes. These observations could
revolutionize our therapeutic strategies making arterial stiffness and cBP the primary therapeutic targets.
However, more research is needed before applying cBP
parameters into every day clinical practice. The advent of
ambulatory monitoring of cBP and probably, in the long
term of arterial stiffness, will be a determining factor in the
effort to understand the masked properties of central hemodynamic components. With only a few trials published so
far, it is undoubtedly a virgin field for future cardiovascular
novelties.
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